Rhythm Pharmaceuticals Inc (RYTM)
NASDAQ:RYTM
Advertisement

Rhythm Pharmaceuticals (RYTM) Revenue

Compare
558 Followers

Rhythm Pharmaceuticals Revenue

Rhythm Pharmaceuticals had a revenue of 51.30M in the quarter ending Sep 30, 2025, with 5.76%. This bring the company's revenue in the last twelve months to 174.33M, Decreased 11.55%. In the fiscal year ending Dec 31, 2024, Rhythm Pharmaceuticals had annual revenue of 130.13M with 68.06% growth.
Revenue (ttm)
174.33M
Revenue Growth
54.92%
P/S Ratio
50.22
Revenue/Employee
$459,809
Employees
283
Market Cap
$6.53B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
130.13M52.70M+168.06%
Dec 31, 2023
77.43M53.79M+327.56%
Dec 31, 2022
23.64M20.48M+749.46%
Dec 31, 2021
3.15M-315,400,000.00%
Dec 31, 2020
Dec 31, 2019
Dec 31, 2018
Dec 31, 2017
Dec 31, 2016
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis